Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.
about
Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's diseaseGenetically engineered mouse models of Parkinson's diseaseThe complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's diseaseInhibition of microglia activation as a phenotypic assay in early drug discoveryProteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson diseaseInflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?M1 and M2 immune activation in Parkinson's Disease: Foe and ally?Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityMicroglia development and functionLow concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic studyIminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff diseaseGlial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.Chondrocyte-specific pathology during skeletal growth and therapeutics in a murine model of pseudoachondroplasiaThe anti-inflammatory role of tissue inhibitor of metalloproteinase-2 in lipopolysaccharide-stimulated microgliaApoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation.Role of oxidative stress in Parkinson's disease.Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme ActivityThe endotoxin-induced neuroinflammation model of Parkinson's disease.Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.Apoptosis signal-regulating kinase 1 modulates the phenotype of α-synuclein transgenic mice.Autophagic impairment contributes to systemic inflammation-induced dopaminergic neuron loss in the midbrain.Association studies of MMP-9 in Parkinson's disease and amyotrophic lateral sclerosis.Expression of mutant alpha-synuclein modulates microglial phenotype in vitroα-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson diseaseRole of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's diseaseDopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators.β-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microgliaA brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease.Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T MutantTransmission of Soluble and Insoluble α-Synuclein to Mice.The changing phenotype of microglia from homeostasis to diseaseAssociations of Matrix Metalloproteinase-9 and Tissue Inhibitory Factor-1 Polymorphisms With Parkinson Disease in Taiwan.microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein.Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synucleinInflammation induced by MMP-9 enhances tumor regression of experimental breast cancerHuman neuromelanin: an endogenous microglial activator for dopaminergic neuron deathProtein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
P2860
Q24630237-A63F13A4-72A5-4E9C-BADD-F96F02DE68E2Q26852964-03AD6189-41D2-493A-B83A-FC4E2814871AQ26853537-9F54B7F0-6E72-4666-A0EA-E476C1FEB8B9Q26996061-44B84110-7002-4F85-8C4F-6BA4610B3408Q27005843-4905FD91-C82D-4A36-B85F-7A81163936FFQ27022728-90F3B869-5B53-4E25-A1BE-4F53247791FEQ27024667-FFEF6198-1877-4E6B-9ABA-D5DE86BC0D2EQ27027973-EE973EDB-9384-4365-A1C5-8FB557941D9EQ27316453-07997123-EB71-4ACB-8AFA-3E63D2C34546Q28477457-7ED8DF5F-D625-4288-808D-85DC63AEACB5Q28478879-97DCF212-AFB0-4C2B-8508-26133659F261Q30991616-62D61AD7-2F9E-4DE4-9B6B-90A331FB5ED4Q33821143-4CEA2E08-91DE-4A09-B6DE-E44BDB603915Q33880665-B041139A-89BA-4E81-8F91-9257947FBDCBQ34130806-0AB65009-A563-4CC4-B625-DFC570FD628EQ34339252-FD3129A1-3056-44B6-95B0-199CA54B1B1EQ34360507-0E5AD807-BFDC-4E9D-874D-435C01432F14Q34557246-E03B39DD-8E85-40E4-BCD6-D36EEDACD667Q34576478-F980BD72-DA7C-4788-A8E1-BB4D546B96F8Q34717871-B69F2CC0-A555-4E3D-9AEB-54716AAC31E7Q34925928-A49F052F-0F6B-43D7-BBD9-C7470A95F61FQ34989297-26F740E3-B947-4208-B5FC-078CFE043B8EQ35014520-D4A2BB61-C2F4-4DCD-8364-585B6512DC23Q35100189-2ED53D02-B12C-4CB4-B32E-B49F5D60DE48Q35510197-8018F3E6-C2CB-4A3C-BB86-FA944A550147Q35626938-8F2BD78C-4732-4C61-A931-D8779EFE2610Q35746518-7EEE1BBE-3CC0-43DE-9EC6-54D153981663Q35852416-DDCC5428-0DB8-4E73-8241-6809587BD499Q36086721-5B8741C1-5E26-4A5A-9E67-DD019D372413Q36127050-BCB0F182-746D-4950-A52D-F05807FC14ABQ36131340-1BA21BFC-A56E-4F10-B2E3-574A4D75980FQ36303655-A05BFA3E-F42F-4132-B223-75501BEE43C1Q36444472-12C8129A-515A-4FBA-972A-7662795A18D8Q36566963-821FEB55-7B0D-4A9F-BA73-21AB9A01E719Q36610305-32769283-78F1-4AC7-8B8E-E148486A1A44Q36640417-86BA81FE-D88D-4355-A250-00369220DD9AQ36658992-9B7EEECD-50BC-45C2-A71B-D237817BE59BQ36748236-33643B86-DEBF-4E42-88BA-01BE130D7253Q36766407-43A68288-4A33-44AB-9E6F-B3D51566BF5CQ37198050-4BCAD8E5-98CE-404C-82CF-3D7FE68D8F83
P2860
Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Alpha-synuclein activates micr ...... protease-activated receptor-1.
@en
type
label
Alpha-synuclein activates micr ...... protease-activated receptor-1.
@en
prefLabel
Alpha-synuclein activates micr ...... protease-activated receptor-1.
@en
P2093
P356
P1476
Alpha-synuclein activates micr ...... protease-activated receptor-1.
@en
P2093
Eun-Jung Lee
Eunsung Junn
Hee-Sun Kim
In-Young Choi
Moon-Chang Baek
Moon-Sook Woo
Pyong-Gon Moon
Won-Ki Kim
P304
P356
10.4049/JIMMUNOL.0903480
P407
P577
2010-05-28T00:00:00Z